New DNA Test Determines Cannabis Compatibility

Endocanna Health Creates New Paradigm of Personalized Medicine Connecting Human DNA with Cannabis Genetic Profiles

CALIFORNIA: Endocanna Health this week launches its Cannabinoid DNA Variant Test”  — billed as the most comprehensive personalized cannabis DNA test available on the market today. Developed by a team of renowned scientists at Endocanna Heath, a biotechnology research company, this direct-to-consumer DNA test kit, analyzes an individual’s DNA markers and provides science backed recommendations based on their specific DNA in a way no other test has been able to do before.

Until now, there was no comprehensive way to test one’s unique DNA and align it with the latest research to predict how humans may respond to cannabis. For example, some individuals with a specific variant in the gene CYP2C9 may not metabolize THC well and should be cautious about consuming edible products. The test also screens for genetic variants linked to the tendency to experience greater levels of anxiety, drug dependence, and a host of other traits. Therefore, this test allows people to have positive outcomes, helps individuals demystify their cannabis experiences, and further establishes cannabis as a viable solution to alleviate health and wellness issues.

Endocanna HealthEndocanna Health utilizes a patent pending algorithm and process to develop its Cannabinoid DNA Variant Report™. DNA for the test is obtained through either a simple saliva swab or existing genetic data from popular DNA testing services like Ancestry, 23andMe, Family Tree DNA or MyHeritageDNA. Consumers can then use their personalized reports to discover the right products for their specific genetics with product suggestions from Endocanna Heath, providing a full spectrum experience.

“Our goal in establishing Endocanna Health is simple,” says Len May, Endocanna Health co-founder and CEO, “to provide individuals with the tools and confidence to incorporate cannabis into their lives using the most up-to-date research available today. Information that is accurate, but most importantly personal and unique to an individual’s DNA. The goal of our reports is to help people identify which products may help them, and try to give them the best possible outcomes with cannabis. We are gratified to help the millions of people who use cannabis or who may want to begin using cannabis make the most informed decisions when it comes to using the plant.”

Front Range Biosciences Partners With University of California, Davis For Cannabis Genomics Research

Agricultural biotech company collaborates with world’s leading agriculture school for research

CALIFORNIA: Front Range Biosciences, a leading agricultural biotech company, has launched a genomics research initiative with the University of California, Davis, to advance understanding of cannabis for medical and nutraceutical uses.  The research team consists of Professor Dario Cantu in the Department of Viticulture and Enology, research scientists in the Cantu lab, and members of the FRB team.

“We have successfully applied cutting-edge DNA sequencing technologies and computational approaches to study challenging genomes of diverse crops and associated microorganisms. We are now excited to have the opportunity to study the genome of hemp. Decoding its genome will allow us to gain new insight into the genetic bases of complex pathways of secondary metabolism in plants,” said Dr. Cantu.

“UC Davis is renowned as the leading agriculture university in the world and we are excited to work with Dr. Cantu’s team to improve this crop to reduce pesticide residues and excessive application of fertilizers, in preparation for production targeting medically beneficial compounds,” said Dr. Jonathan Vaught, CEO of FRB.

During the project, FRB will isolate DNA from hemp cultivars that are low in THC and solely for industrial uses. The company will send these DNA samples to UC Davis for Next-Generation Sequencing and bioinformatic analysis to create a better genome reference for cannabis.

To fund the project, FRB pledged a gift, to be fulfilled over a one-year period, to The Regents of University of California to support UC Davis’ development and annotation of the cannabis genome. FRB gift will cover costs related to supplies, DNA and RNA sequencing, assembly and annotation of the cannabis genome.